| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 12, 2004
Accepted on October 7, 2004
in Normal and Endometriotic Stromal Cells
The Institute of Clinical Medicine, Department of Obstetrics and Gynecology, The Institute of Molecular Medicine, Department of Physiology, and Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan, Republic of China
Aberrant production of cyclooxygenase-2 (COX-2) plays pivotal roles in many pathological processes including tumorigenesis and endometriosis though the underlying mechanism remains obscure. Herein we report evidence to demonstrate that COX-2 is distinctly regulated by interleukin-1
(IL-1
) in normal and endometriotic stroma. Ectopic endometriotic stromal cell is, at least, 100 times more sensitive to IL-1
treatment compared with its eutopic counterpart. Induction of COX-2 expression in normal endometrial stroma by IL-1
is primary due to enhancement of COX-2 mRNA stability. In contrast, IL-1
not only increased COX-2 mRNA stability but also up-regulated COX-2 promoter activity in ectopic endometriotic stroma. Induction of COX-2 promoter activity by IL-1
is mediated via mitogen-activated protein kinase-dependent phosphorylation of cAMP-responding element binding protein (CREB). Promoter activity and electrophoretic motility shift assays demonstrate that a CRE site located at -571/-564 of COX-2 promoter is critical for IL-1
-induced COX-2 gene expression. Our results indicate that elevation of COX-2 expression in endometriotic tissues may result from increased sensitivity to proinflammatory cytokines such as IL-1
, which is consistently present in the peritoneal fluid of endometriosis patients. Distinct regulation of COX-2 gene by IL-1
may play critical role in pathophysiological process such as cancer formation and endometriosis.
PGE2
Transcriptional regulation
This article has been cited by other articles:
![]() |
O. Celik, S. Hascalik, K. Elter, M.E. Tagluk, B. Gurates, and N.E. Aydin Combating endometriosis by blocking proteasome and nuclear factor-{kappa}B pathways Hum. Reprod., August 2, 2008; (2008) den246v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Hsu, C.-W. Lu, B.-M. Huang, M.-H. Wu, and S.-J. Tsai Cyclic Adenosine 3',5'-Monophosphate Response Element-Binding Protein and CCAAT/Enhancer-Binding Protein Mediate Prostaglandin E2-Induced Steroidogenic Acute Regulatory Protein Expression in Endometriotic Stromal Cells Am. J. Pathol., August 1, 2008; 173(2): 433 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Wu, K.-F. Chen, S.-C. Lin, C.-W. Lgu, and S.-J. Tsai Aberrant Expression of Leptin in Human Endometriotic Stromal Cells Is Induced by Elevated Levels of Hypoxia Inducible Factor-1{alpha} Am. J. Pathol., February 1, 2007; 170(2): 590 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Kang, B. A. Wingerd, T. Arakawa, and W. L. Smith Cyclooxygenase-2 Gene Transcription in a Macrophage Model of Inflammation J. Immunol., December 1, 2006; 177(11): 8111 - 8122. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-C. Chuang, H. S. Sun, T.-M. Chen, and S.-J. Tsai Prostaglandin E2 Induces Fibroblast Growth Factor 9 via EP3-Dependent Protein Kinase C{delta} and Elk-1 Signaling Mol. Cell. Biol., November 15, 2006; 26(22): 8281 - 8292. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Achache and A. Revel Endometrial receptivity markers, the journey to successful embryo implantation Hum. Reprod. Update, November 1, 2006; 12(6): 731 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Attar and S.E. Bulun Aromatase and other steroidogenic genes in endometriosis: translational aspects Hum. Reprod. Update, January 1, 2006; 12(1): 49 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Wu, Y. Shoji, M.-C. Wu, P.-C. Chuang, C.-C. Lin, M.-F. Huang, and S.-J. Tsai Suppression of Matrix Metalloproteinase-9 by Prostaglandin E2 in Peritoneal Macrophage Is Associated with Severity of Endometriosis Am. J. Pathol., October 1, 2005; 167(4): 1061 - 1069. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |